|Articles|October 7, 2019

PFF Launches Drug Development Pipeline Tool

The Pulmonary Fibrosis Foundation has launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis community.

To learn more, click here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
September 15th 2025
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
September 15th 2025
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
September 15th 2025
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients
September 12th 2025

PFF Launches Drug Development Pipeline Tool

Newsletter

Related Articles

Trending on Applied Clinical Trials Online

NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG

Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease

ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research

Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome